Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A. Wagner, Andrea Fava, Ben L. Jones, Peter Izmirly, Michael H Belmont, Robert M. Clancy, Jennifer H. Anolik, Jennifer L. Barnas, Chaim Putterman, David Wofsy, Michael H. Weisman, Anne Davidson, Derek Michael Fine, Vernon Michael Holers, , Judith A. James
The paper uses serum proteomics to identify molecular signatures that classify lupus nephritis, differentiate disease activity and chronicity, and predict treatment response.
bioRxiv · May 12, 2026 · PreprintImmunology